Literature DB >> 20981468

Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.

A Heinold1, B Hanebeck, V Daniel, J Heyder, T H Tran, B Döhler, J Greil, F-M Müller.   

Abstract

Here, we report on a male infant with low serum IgG, IgA and IgM levels who suffered from Pneumocystis jirovecii and cytomegalovirus (CMV) pneumonia. The patient was tested to be HIV-negative. Absolute and relative numbers of lymphocyte subsets were normal, excluding the diagnosis of an X-linked agammaglobulinaemia (Bruton's disease). Despite the decreased serum IgM level, an X-linked hyper-IgM syndrome (X-HIGM) was considered. X-HIGM is a rare immunodeficiency usually characterised by recurrent severe opportunistic infections, low serum IgG and IgA, but normal or increased serum IgM. The syndrome is caused by mutations of the CD40 ligand (CD40L) gene. In our patient, CD40L mutation analysis proved a novel mutation at codon 257 associated with non-detectable expression of CD40L on the surface of activated T cells. A literature search revealed that approximately 6.4% of X-HIGM patients had been found to have low serum IgM levels. Our statistical analysis of the IgM levels as reported by different studies arouses suspicion that many patients with low IgM levels may not have undergone diagnostic procedures for X-HIGM. In summary, in this report and critical review of the literature, we described a new mutation of CD40L and highlighted the pitfalls of the diagnosis of X-HIGM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981468     DOI: 10.1007/s15010-010-0061-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  41 in total

1.  Clinical spectrum of X-linked hyper-IgM syndrome.

Authors:  J Levy; T Espanol-Boren; C Thomas; A Fischer; P Tovo; P Bordigoni; I Resnick; A Fasth; M Baer; L Gomez; E A Sanders; M D Tabone; D Plantaz; A Etzioni; V Monafo; M Abinun; L Hammarstrom; T Abrahamsen; A Jones; A Finn; T Klemola; E DeVries; O Sanal; M C Peitsch; L D Notarangelo
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

Review 2.  Hyper IgM syndrome: the other side of the coin.

Authors:  R L Fuleihan
Journal:  Curr Opin Pediatr       Date:  2001-12       Impact factor: 2.856

3.  A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency.

Authors:  B Ostenstad; S Giliani; O J Mellbye; B R Nilsen; T Abrahamsen
Journal:  Clin Exp Immunol       Date:  1997-02       Impact factor: 4.330

Review 4.  Immunodeficiency mutation databases (IDbases).

Authors:  Hilkka Piirilä; Jouni Väliaho; Mauno Vihinen
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

5.  CD40 ligand deficiency presenting as unresponsive neutropenia.

Authors:  F J Andrews; F Katz; A Jones; S Smith; A Finn
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

6.  Molecular characterization of patients with X-linked Hyper-IgM syndrome: description of two novel CD40L mutations.

Authors:  A Rangel-Santos; V L Wakim; C M Jacob; A C Pastorino; J M Cunha; A C Collanieri; J E Niemela; A S Grumach; A J S Duarte; D Moraes-Vasconcelos; J B Oliveira
Journal:  Scand J Immunol       Date:  2009-02       Impact factor: 3.487

7.  Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM.

Authors:  K C Gilmour; D Walshe; S Heath; G Monaghan; S Loughlin; T Lester; G Norbury; C M Cale
Journal:  Mol Pathol       Date:  2003-10

Review 8.  The role of gp39 (CD40L) in immunity.

Authors:  R J Noelle
Journal:  Clin Immunol Immunopathol       Date:  1995-09

9.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

10.  [Hyper-IgM syndrome in a boy with recurrent pneumonia and hepatosplenomegaly].

Authors:  Dragana Janić; Nedeljko Radlović; Lidija Dokmanović; Nada Krstovski; Zoran Leković; Srdja Janković; Dragana Ristić
Journal:  Srp Arh Celok Lek       Date:  2009 Jan-Feb       Impact factor: 0.207

View more
  4 in total

1.  X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene.

Authors:  Tian-Jiao Wang; Li-Fang Wu; Junguo Chen; Wen Zhu; Hua Wang; Xiao-Lin Liu; Yi-Qun Teng
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

2.  Generation of mice with conditional ablation of the Cd40lg gene: new insights on the role of CD40L.

Authors:  Angélica Horrillo; Tomás Fontela; Elena G Arias-Salgado; Dolores Llobat; Gracia Porras; Matilde S Ayuso; Consuelo González-Manchón
Journal:  Transgenic Res       Date:  2013-09-13       Impact factor: 2.788

3.  An X-Linked Hyper-IgM Patient Followed Successfully for 23 Years without Hematopoietic Stem Cell Transplantation.

Authors:  Necil Kutukculer; Neslihan Edeer Karaca; Guzide Aksu; Ayca Aykut; Erhan Pariltay; Ozgur Cogulu
Journal:  Case Reports Immunol       Date:  2018-10-14

4.  Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant: A case report.

Authors:  Danbi Kim; Ju Ae Shin; Seung Beom Han; Nack-Gyun Chung; Dae Chul Jeong
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.